NCT01110967

Brief Summary

The Satellite™ Retrospective Analysis is an international, retrospective, multi-center, non-interventional post-marketing study designed to document and analyze existing data with the device in a "real-world" setting. The purpose of this study is to evaluate number of adverse device effects (ADEs), serious adverse device effects (SADEs) and serious adverse event (SAEs) and early clinical effectiveness for the Satellite™ Nucleus Replacement in a standard clinical practice. Data collection will include information on health related quality of life (QoL), physical functioning and adverse event after nucleus replacement surgery. Radiographic measures will also be assessed to evaluate changes in disc height at the operated level and changes in segmental range of motion. All patients who were implanted with a Satellite™ Nucleus Replacement Prosthesis in the participating sites are eligible for participation in the Satellite ™ Retrospective Analysis.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2010

Geographic Reach
3 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

April 15, 2010

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 27, 2010

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2011

Completed
2.9 years until next milestone

Results Posted

Study results publicly available

August 7, 2014

Completed
Last Updated

January 28, 2016

Status Verified

January 1, 2016

Enrollment Period

1.5 years

First QC Date

April 15, 2010

Results QC Date

May 13, 2014

Last Update Submit

January 26, 2016

Conditions

Outcome Measures

Primary Outcomes (4)

  • Health-related Quality of Life Using the Visual Analogue Scale for Back Pain

    The Visual Analogue Scale (VAS) is a tool widely used to measure pain. It is a 10 cm scale, 0cm means 'no pain' and 10cm means 'worst possible pain'. The patients mark the location corresponding to the amount of back pain they experienced on the 10cm line.

    Up to 12 months follow up visit

  • Health-related Quality of Life Using the Visual Analogue Scale for Leg Pain

    The Visual Analogue Scale (VAS) is a tool widely used to measure pain. It is a 10 cm scale, 0cm means 'no pain' and 10cm means 'worst possible pain'. The patients mark the location corresponding to the amount of back pain they experienced on the 10cm line.

    Up to 12 months follow up visit

  • Physical Functioning Using the Oswestry Disability Index (ODI)

    The Oswestry Disability Index (ODI) derives from the Oswestry Low Back Pain Questionnaire, it is used to measure disability for low back pain. The index is scored from 0 to 50; 0 meaning 'no disability' and 50 meaning 'maximum disability'.

    Up to 12 months follow up visit

  • Safety by Evaluating the Number of Serious Adverse Device Effects (SADEs), Adverse Device Effects (ADEs) and Serious Adverse Events (SAEs)

    Patients were followed up according to the local practice, up to 1 year

Secondary Outcomes (4)

  • Range of Motion (ROM) at Implanted Level

    Up to 12 months follow up visit

  • Intervertebral Disc Space (IVD) at Implanted Level

    Up to 12 months follow up visit

  • Device Subsidence Measured as Interbody Height Ratio (IBHR)

    Up to 12 months follow up visit

  • Changes in Device Placement

    Up to 12 months follow up visit

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients who were implanted with a Satellite™ Nucleus Replacement device at the participating sites are eligible for participation in the Satellite ™ Retrospective Analysis.

You may qualify if:

  • Patient must have signed a Patient Data Release Form
  • Age of at least 18 years and skeletally mature at the time of surgery
  • Patient has not reached the age of legal consent according to local laws

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Masaryk Hospital

Ústí nad Labem, Czechia

Location

ÚVN SNP

Ružomberok, Slovakia

Location

Instituto de Columna de Caracas

Caracas, Venezuela

Location

MeSH Terms

Conditions

Intervertebral Disc DegenerationIntervertebral Disc Displacement

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal DiseasesHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Limitations and Caveats

Due to the retrospective design, it was not possible to report on SF-36 results and Modic endplate changes results as limited data was available in the patient records.

Results Point of Contact

Title
Cristina Faria
Organization
Medtronic Spinal & Biologics

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 15, 2010

First Posted

April 27, 2010

Study Start

April 1, 2010

Primary Completion

October 1, 2011

Study Completion

October 1, 2011

Last Updated

January 28, 2016

Results First Posted

August 7, 2014

Record last verified: 2016-01

Locations